Physical activity for diabetes-related depression: A systematic review and meta-analysis

Narita, Zui; Inagawa, Takuma; Stickley, Andrew; Sugawara, Norio

doi:10.1016/j.jpsychires.2019.03.014

Cited by 31 publications

(32 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Elderly people who have good physical capabilities and activity can generally go for walks, exercise, and talk with people in the community; and as a result their mood can be relatively pleasant, with a lower risk of depression. This is similar to the conclusions reported by Narita et al, where physical activity helped ameliorate depression in patients with diabetes [46]. Elderly people with multiple diseases are also likely to suffer from depression, which is similar to the findings of another recent study [47].…”

Section: Discussionsupporting

confidence: 92%

Risk factors for depression in elderly diabetic patients and the effect of metformin on the condition

Chen

Wei²,

Wang

et al. 2019

BMC Public Health

View full text Add to dashboard Cite

Background At present, only a few studies have focused on the risk factors for depression in elderly diabetic patients, and there is little evidence for the effect of metformin in depressed elderly patients with diabetes than on its effect on blood glucose. The aim of the current work was to study the risk factors for depression in elderly diabetic patients and to ascertain the effects of metformin on the depressive state. Methods We initiated a 1:4 matched case–control study. The case group comprised 110 elderly diabetic patients with depression from nine communities in Shenyang in 2017. The control group comprised 440 non-depressed elderly diabetic patients from the same communities, which were matched by gender and age (± 2 years of age) with the case group. Depression was measured using the Geriatric Depression Scale-15, and we performed matched univariate and multivariate logistic regression analyses. Results In the multivariate analysis, overweight status, poor physical capabilities and low activity level, and the presence of more than two additional illnesses were risk factors for depression in elderly patients with diabetes. For these risk factors, the adjusted ORs (all P < 0.05) were as follows: an adjusted OR of 2.031 and 95% CI of 1.180–3.495; an adjusted OR of 2.342 and 95% CI of 1.465–3.743; and an adjusted OR of 5.350 and 95% CI of 2.222–12.883, respectively. Patients taking metformin had a lower risk of depression than those taking no medication, with an adjusted OR of 0.567 and 95% CI of 0.323–0.997 ( P < 0.05). Conclusions Overweight status, poor physical capabilities and low activity level, and the presence of more than two additional illnesses were risk factors for depression in elderly diabetic patients, and metformin was a protective factor against depression in elderly diabetic patients.

show abstract

Section: Discussionsupporting

confidence: 92%

Risk factors for depression in elderly diabetic patients and the effect of metformin on the condition

Chen

Wei²,

Wang

et al. 2019

BMC Public Health

View full text Add to dashboard Cite

show abstract

“…Symptoms of depression and/or anxiety are reduced not only among patients with a clinical diagnosis of depression and/or anxiety but also in patients with other diseases, including diabetes, arthritis and other rheumatic diseases, Alzheimer’s disease, multiple sclerosis, and renal disease; cancer survivors and HIV-positive individuals also saw a reduction in such symptoms (Table 3) [40-48]. The evidence for the reduction of depression is strongest among breast cancer and lymphoma patients [44].…”

Section: Methodsmentioning

confidence: 99%

Summary of the Effects of Exercise Therapy in Non-Communicable Diseases: Clinically Relevant Evidence from Meta-Analyses of Randomized Controlled Trials

Kujala

2021

Preprint

View full text Add to dashboard Cite

There is strong evidence that exercise therapy leads to better measured and self-reported physical fitness and function in patients with chronic diseases, along with improvements in body composition. The evidence for other health benefits has not been summarized as systematically across different chronic diseases. Given the volume of research that has appeared in the past decade, this review of meta-analyses of randomized controlled trials (RCTs) in patients with specific chronic diseases summarizes the evidence regarding exercise therapy for various outcomes to help practitioners in prescribing exercise therapy for their patients. Meta-analyses published before Jan 1, 2021, based on at least four RCTs, and investigating the effect of exercise therapy on the same outcome among patients with a specific chronic disease were screened. These meta-analyses show that, in addition to improvements in fitness and function, various cardio-metabolic risk factor levels are improved in most of the common cardio-metabolic diseases, pain is reduced in musculoskeletal diseases, mood (depression and anxiety) and health-related quality of life are improved in various disease categories, and disease-specific indicators of disease progression are improved for conditions such as type 2 diabetes, hypertension, coronary heart disease, heart failure, claudication, chronic obstructive pulmonary disease, rheumatoid arthritis, fibromyalgia, depression, anxiety, and schizophrenia. Physicians should consider prescribing exercise to their patients with chronic disease conditions to improve their physical fitness, mood, and health-related quality of life and to slow down the progression of disease. This improves a patient's possibility to enjoy an active and independent life.

show abstract

“…In addition, for T2DM patients whose depressive symptom was screened out, subsequent monitoring of depression symptoms and intensive treatment of depression are important and appear to successful [42] . For examples, both physical activity intervention and cognitive behavioral therapy are bene cial in improving depression for patients with T2DM [43,44] . Therefore, detection and treatment of depression as early as possible are crucial for T2DM population.…”

Section: Discussionmentioning

confidence: 99%

Prevalence and Risk Factors of Depression in Chinese Patients With Type 2 Diabetes Mellitus: a Protocol of Systematic Review and Meta-analysis

LIU

Chen²,

Jiang³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: The prevalence of type 2 diabetes mellitus (T2DM) is growing in China. Both physical and psychological complications occur along with the development of T2DM. The patients with depression account for a significant proportion of T2DM. Depressive symptoms interfere with blood glucose management, leading to poorer treatment outcome and even relate to the occurrence of other serious complications of T2DM population. Among these T2DM patients with depression, early detection and treatment is essential and effective. Knowledge of the current prevalence of depression in T2DM patients as well as associated risk factors may be meaningful for healthcare planning. Therefore, we plan to conduct a systematic review and meta-analysis to evaluate the Chinese prevalence of depression in T2DM and explore associated risk factors.Methods: We will search literatures recorded in MEDLINE/PubMed, EMBASE, the Cochrane Library, Chinese Biomedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), Chinese Science and Technology Periodical Database (VIP), and Wanfang database (Wanfang Data). The grey literatures and reference list will be manually searched. We will include population-based, cross-sectional surveys that investigated the Chinese prevalence of depression in T2DM or/and researched the possible risk factors. Two reviewers will screen studies, extract data and evaluate quality independently. We will assess inter-rater agreement between reviewers for study inclusion, data extraction, and study quality assessment using Kappa statistics. The primary outcome will be the pooled Chinese prevalence of depression in T2DM patients. The secondary outcome will contain the potential risk factors for depression in patients with T2DM. R software (version 3.6.1) and STATA software (version 12) will be used for data analysis.Discussion: This systematic review will provide comprehensive evidence of the Chinese prevalence and risk factors of depression in patients with T2DM. we expect to provide evidence basis for healthcare practitioners and policy makers to pay attention to the mental health of T2DM. Our data will highlight the need and importance of early detection and intervention for depression in patients with T2DM. Systematic review registration: PROSPERO CRD42020182979.

show abstract

Physical activity for diabetes-related depression: A systematic review and meta-analysis

Cited by 31 publications

References 43 publications

Risk factors for depression in elderly diabetic patients and the effect of metformin on the condition

Risk factors for depression in elderly diabetic patients and the effect of metformin on the condition

Summary of the Effects of Exercise Therapy in Non-Communicable Diseases: Clinically Relevant Evidence from Meta-Analyses of Randomized Controlled Trials

Prevalence and Risk Factors of Depression in Chinese Patients With Type 2 Diabetes Mellitus: a Protocol of Systematic Review and Meta-analysis

Contact Info

Product

Resources

About